Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma

This study has been completed.
Information provided by (Responsible Party):
Array BioPharma Identifier:
First received: November 5, 2013
Last updated: July 27, 2016
Last verified: July 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2016
  Primary Completion Date: February 2016 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: April 15, 2016